Skip to main content

Of Cells and Limits

Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.

Written byAnna Azvolinsky
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00

LEONARD HAYFLICK
Adjunct Professor of Anatomy
University of California, San Francisco
© RAMIN RAHIMIAN
Leonard Hayflick learned to culture cells under the tutelage of a famous expert, Charles Pomerat. In 1958, after completing his fellowship in Pomerat’s lab, Hayflick became a member of the Wistar Institute in Philadelphia, providing cell cultures for its researchers. “It was a golden opportunity because it would leave me with plenty of time and resources to do what I wanted to do without worrying about getting grants or being subject to supervision.”

Hayflick was interested in detecting viruses that might cause human cancer. He would extract viruses from the culture fluid in which he grew cancer cells and attempt to transform normal cells into tumor cells. Human adult cells frequently contained unwanted viruses, so Hayflick obtained tissue from fetuses to use as a source of virus-free normal cells. He found that tissue from the lung, which is already a discrete organ by three months of embryonic development, was best for making fibroblast cell strains. “Like everyone else who did cell culture, I was persuaded to believe the 60-year-old dogma that when you culture cells, they have the capacity to divide forever. In practice, this never happened and people attributed their failure to ignorance of culturing methods, media ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile

Related Topics

Published In

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo